Femasys Inc (FEMY): who owns it and who trades it
As of Nov 16, 2026, FEMY insiders reported 3 purchases worth $74K in the last 12 months. The largest buyer was Dov Elefant (CFO), with $50K. 1 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Femasys
From the latest filingsOverall: more buying than selling. Insiders and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Insider trades
In the last 12 months, FEMY insiders reported $74K of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Jeffrey Gerald Mifek | Chief Clinical-Medical A | Purchase | 3,125 | $3.20 | $10K | Form 4 |
| Aug 7, 2026 | John Charles Canning | Chief Operating Officer | Purchase | 4,375 | $3.20 | $14K | Form 4 |
| Aug 7, 2026 | Dov Elefant | CFO | Purchase | 15,625 | $3.20 | $50K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Dov Elefant | Chief Financial Officer | $50K | – | Aug 7, 2026 |
| John Charles Canning | Chief Operating Officer | $14K | – | Aug 7, 2026 |
| Jeffrey Gerald Mifek | Chief Clinical-Medical Affairs | $10K | – | Aug 7, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
FEMY short interest
Low short interest. 0.6% of FEMY shares are sold short: about 1 share in 170. Over the last 12 reports the number of shares short went down 97%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 49,266 FEMY shares were sold short, 0.6% of the shares outstanding, down 70.0% from the report before. At the average daily volume of 100,794 shares, buying them all back would take about 1.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 49,266 | 0.59% | -70% | 100,794 | 1.0 |
| Oct 15, 2026 | 164,106 | 1.96% | -72% | 108,262 | 1.5 |
| Sep 30, 2026 | 577,249 | 6.89% | -6% | 78,475 | 7.4 |
| Sep 15, 2026 | 612,619 | 7.31% | +3% | 72,493 | 8.4 |
| Aug 31, 2026 | 593,056 | 7.08% | +36% | 3.60M | 1.0 |
| Aug 14, 2026 | 434,999 | 5.19% | +64% | 274,553 | 1.6 |
| Jul 31, 2026 | 264,928 | 0.44% | +36% | 62,071 | 4.3 |
| Jul 15, 2026 | 194,148 | 0.32% | +2% | 30,714 | 6.3 |
| Jun 30, 2026 | 190,234 | 0.32% | -4% | 42,768 | 4.5 |
| Jun 15, 2026 | 198,600 | 0.33% | -94% | 78,232 | 2.5 |
| May 29, 2026 | 3.33M | 5.51% | +70% | 3.90M | 1.0 |
| May 15, 2026 | 1.96M | 3.24% | +1% | 456,362 | 4.3 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Femasys company events
Femasys filed 16 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership, listing). The latest was on Nov 2, 2026.
- Nov 2, 2026LeadershipKenneth D. Eichenbaum, M.D., M.S.E., informed the Board of Directors of Femasys Inc. of his resignation as a director of the Company, effective as of that date. Filing
- Aug 14, 2026ResultsReleased financial results. Filing
- Aug 11, 2026AgreementFemasys Inc. entered into a Securities Purchase Agreement with certain accredited investors, pursuant to which the Company agreed to issue and sell to the Purchasers in a private placement an aggregate of (i) 5,013,559 shares of the Company’s common stock, par value $0.001 per share, (ii)… Filing
- Jun 24, 2026VoteReported shareholder vote results. Filing
- Jun 24, 2026AnnouncementFemasys Inc. received written notice ( the “Notice”) from The Nasdaq Stock Market LLC that the Company has regained compliance with Nasdaq Listing Rule 5550( a)(2), the minimum bid price requirement for continued listing on The Nasdaq Capital Market, and that this matter is now closed. Filing
- Jun 5, 2026SharesChanged the rights of its shareholders. Filing
- Jun 4, 2026AnnouncementShared information with investors. Filing
- May 13, 2026AnnouncementShared information with investors. Filing
- May 8, 2026ResultsReleased financial results. Filing
- Apr 29, 2026VoteReported shareholder vote results. Filing
- Apr 1, 2026LeadershipFemasys Inc. announced the hiring and appointment of John Canning as its Chief Operating Officer, effective March 30, 2026. Filing
- Mar 31, 2026ResultsReleased financial results. Filing
- Mar 20, 2026LeadershipJoshua Silverman informed the Board of Directors of the Company of his resignation as a director of the Company, effective as of that date. Filing
- Jan 15, 2026ListingAs previously reported, on July 16, 2025, Femasys Inc. received a notice from The Nasdaq Stock Market that the Company is not in compliance with Nasdaq’s Listing Rule 5550(a)(2), as the minimum bid price of the Company’s common stock has been below $1.00 per share for 30 consecutive business days. Filing
- Dec 23, 2025AnnouncementFemasys Inc. filed a prospectus supplement for the offer and sale of shares of its common stock, par value $0.001 per share, having an aggregate offering price of up to $9.8 million, pursuant to the Equity Distribution Agreement, dated July 1, 2022, with Piper Sandler & Co. under which the Company… Filing
- Dec 18, 2025AnnouncementFemasys Inc. issued a press release announcing that Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Femasys financials
Famous investors that hold FEMY
1 of the 50 well-known investors we track reported holding FEMY in their latest 13F filing. The largest position is Ken Griffin's, worth $148K.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 68,479 | $148K | 0.0% | +305% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named FEMY in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | Alumni Capital LP | 13G/A | 10.0% |
| Nov 16, 2026 | Chernett Jorey | 13G/A | 0.0% |
| Nov 16, 2026 | Chernett Jorey | 13G/A | 0.0% |
| Nov 16, 2026 | Alumni Capital LP | 13G/A | 10.0% |
| Oct 15, 2026 | Empery Asset Management, LP | 13G | 5.6% |
| Oct 15, 2026 | Empery Asset Management, LP | 13G | 5.6% |
Questions about Femasys Inc (FEMY) stock
Are FEMY insiders buying or selling?
In the last 12 months, FEMY insiders reported 3 open-market purchases worth $74K and no sales. The latest trade was on Aug 7, 2026. See every trade.
What is the short interest in FEMY?
As of Oct 30, 2026, 49,266 FEMY shares were sold short, 0.6% of the shares outstanding, down 70.0% from the report before. At the average daily volume of 100,794 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.
Which famous investors hold FEMY?
1 of the 50 well-known investors we track reported FEMY in their latest 13F filing, including Ken Griffin. The largest position is worth $148K. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.